NeonMind Files New Provisional Patent Application Covering Novel Mechanism of Weight Loss
Ryan Allway March 22nd, 2022 News, Top News OAKVILLE, ON / ACCESSWIRE / March 22, 2022 / NeonMind Biosciences Inc. (CSE:NEON)(OTCQB:NMDBF)(FRA:6UF) (“NeonMind” or the “Company“), an integrated drug development and wellness company focused on bringing innovative psychedelic-based treatments to people suffering from obesity and mental health disorders, announced today it... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )